Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice

European Journal of Immunology

Volumn 32, Issue 9, 2002, Pages 2551-2561

  Morshed, Sufi Reza M ^a   Mannoor, Kaiissar ^a   Halder, Ramesh C ^a   Kawamura, Hiroki ^a   Bannai, Makoto ^a   Sekikawa, Hiroho ^a   Watanabe, Hisami ^a   Abo, Toru ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Autoimmune disease; CD5+B cell; Liver; NKT cell; Peritoneal cavity

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; GALACTOSYLCERAMIDE; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DNA DENATURATION; IMMUNOREGULATION; INFLAMMATION; LIVER; LIVER CELL; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEINURIA; SPLEEN; T LYMPHOCYTE; THYMOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; ANTIGENS, CD1; ANTIGENS, CD4; ANTIGENS, CD5; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; CROSSES, GENETIC; CYTOPLASM; DISEASE PROGRESSION; DNA; GALACTOSYLCERAMIDES; HEPATOCYTES; KIDNEY GLOMERULUS; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, INBRED NZB; PERITONEAL CAVITY; PROTEINURIA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 0036737837     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200209)32:9<2551::AID-IMMU2551>3.0.CO;2-C     Document Type: Article

References (61)

1. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguch, M. CD1d-restricted and TCR-mediated activation of Vα 14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
2. + NK T lymphocytes. J. Immunol. 1998. 161: 3271-3281.
3. Brossay, L., Naidenko, O., Burdin, N., Matsuda, J., Sakai, T. and Kronenberg, M. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J. Immunol. 1998. 161: 5124-5128.
4. Tangri, S., Brossay, L., Burdin, N., Lee, D. J., Corr, M. and Kronenberg, M. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing. Proc. Natl. Acad. Sci. USA 1998. 95: 14314-14319.
5. + T lymphocytes. Science 1995. 268: 863-865.
6. - T lymphocytes to a microbial antigen. Nature 1992. 360: 593-597.
7. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 1995. 182: 2091-2096.
8. Eberl, G., Lees, R., Smiley, S. T., Taniguchi, M., Grusby, M. J. and MacDonald, H. R. Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells. J. Immunol. 1999. 162: 6410-6419.
9. Makino, Y., Yamagata, N., Sasho, T., Adachi, Y., Kanno, R., Koseki, H., Kanno, M. and Taniguchi, M. Extrathymic development of V α14-positive T cells. J. Exp. Med. 1993. 177: 1399-1408.
10. Fowlkes, B. J., Kruisbeek, A. M., Ton-That, H., Weston, M. A., Coligan, J. E., Schwartz, R. H. and Pardoll, D. M. A novel population of T cell receptor αβ-bearing thymocytes which predominantly expresses a single Vβ gene family. Nature 1987. 329: 251-254.
11. Budd, R. C., Miescher, G. C., Howe, R. C., Lees, R. K., Bron, C. and MacDonald, H. R. Developmentally regulated expression of T cell receptor β chain variable domains in immature thymocytes. J. Exp. Med. 1987. 166: 577-582.
12. - murine thymocytes. Proc. Natl. Acad. Sci. USA 1988. 85: 6082-6086.
13. Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J.-F. and Monteiro, R. C. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 1998. 188: 1831-1839.
14. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-1 and /or IL-10. J. Exp. Med. 1998. 187: 1047-1056.
15. Falcone, M., Yeung, B., Tucker, L., Rodriguez, E. and Sarvetnick, N. A defect in interleukin 12-induced activation and interferon γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J. Exp. Med. 1999. 190: 963-972.
16. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T., Haba, T., Scherer, D. C., Wei, J., Kronenberg, M., Koezuka, Y. and Kaer, L. V. The natural killer T cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nature Medicine 2001. 7: 1052-1056.
17. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q.-S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M., Leite-De, M. M., Gourin, C., Zhu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., Lehuen, A., Boch, J. F. and Herbelin, A. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
18. Takeda, K. and Dennert, G. The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J. Exp. Med. 1993. 177: 155-164.
19. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 1996. 156: 4035-4040.
20. Segal, B. M. and Shevach, E. M. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 1996. 184: 771-775.
21. Osman, Y., Kawamura, T., Naito, T., Takeda, K., Kaer, L. V., Okumura, K. and Abo, T. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 2000. 30: 1919-1928.
22. Jones, L. A., Chin, L. T., Merriam, G. R., Nelson, L. M. and Kruisbeck, A. M. Failure of clonal deletion in neonatally thymectomized mice: tolerance is preserved through clonal anergy. J. Exp. Med. 1990. 172: 1277-1285.
23. Bonomo, A., Kehn, P. J., Payer, E., Rizzo, L., Cheever, A. W. and Shevach, E. M. Pathogenesis of post-thymectomy autoimmunity role of syngeneic MLR-reactive T cells. J. Immunol. 1995. 154: 6602-6611.
24. Hammond, K., Cain, W., van Driel, I. and Godfrey, D. Three day neonatal thymectomy selectively depletes NK1.1+ T cells. Int. Immunol. 1998. 10: 1491-1499.
25. Moroda, T., Iiai, T., Kawachi, Y., Kawamura, T., Hatakeyama, K. and Abo, T. Restricted appearance of self-reactive clones into intermediate T cell receptor cells in neonatally thymectomized mice with autoimmune disease. Eur. J. Immunol. 1996. 26: 3084-3091.
26. + B cells in the liver of autoimmune (NZBxNZW) F1 mice. Microbiol. Immunol. 1993. 37: 221-228.
27. Hardy, R. R. and Hayakawa, K. Development and physiology of Ly-1B and its human homolog, Leu-1B. Immunol. Rev. 1986. 93: 53-79.
28. Hayakawa, K., Hardy, R. R., Parks, D. R. and Herzenberg, L. A. The "Ly-1B" cell subpopulation in normal, immunodefective, and autoimmune mice. J. Exp. Med. 1983. 157: 202-218.
29. Ohteki, T., Okuyama, R., Seki, S., Abo, T., Sugiura, K., Kusumi, A., Ohmori, T., Watanabe, H. and Kumagai, K. Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J. Immunol. 1992. 149: 1562-1570.
30. Iiai, T., Watanabe, H., Seki, S., Sugiura, K., Hirokawa, K., Utsuyama, M., Takahashi-Iwanaga, H., Iwanaga, T., Ohteki, T., and Abo, T. Ontogeny and development of extrathymic T cells in mouse liver. Immunology 1992. 77: 556-563.
31. low NKT cells by an alternative intrathymic pathway when restored from acute thymic atrophy. Clin. Exp. Immunol. 1999. 117: 587-595.
32. Shimizu, T., Kawamura, T., Miyaji, C., Oya, H., Bannai, M., Yamamoto, S., Weerasinghe, A., Halder, R. C., Watanabe, H., Hatakeyama, K. and Abo, T. Resistance of extrathymic T cells to stress and a role of endogenous glucocorticoids in stress-associated immunosuppression. Scand. J. Immunol. 2000. 51: 285-292.
33. Seki, S., Abo, T., Sugiura, K., Ohteki, T., Kobata, T., Yagita, H., Okumura, K., Rikiishi, H., Masuda, T. and Kumagai, K. Reciprocal T cell responses in the liver and thymus of mice injected with syngeneic tumor cells. Cell. Immunol. 1991. 137: 46-60.
34. Kimura, M., Hanawa, H., Watanabe, H., Ogawa, M. and Abo, T. Synchronous expansion of intermediate TCR cells in the liver and uterus during pregnancy. Cell. Immunol. 1995. 162: 16-25.
35. Minagawa, M., Narita, J., Tada, T., Maruyama, S., Shimizu, T., Bannai, M., Oya, H., Hatakeyama, K. and Abo, T. Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell. Immunol. 1999. 196: 1-13.
36. Weerasinghe, A., Kawamura, T., Moroda, T., Seki, S., Watanabe, H. and Abo, T. Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation. Cell. Immunol. 1998. 185: 14-29.
37. Abo, T., Ohteki, T., Seki, S., Koyamada, N., Yoshikai, Y., Masuda, T., Rikiishi, H., and Kumagai, K. The appearance of T cells bearing self-reactive T cell receptor in the livers of mice injected with bacteria. J. Exp. Med. 1991. 174: 417-424.
38. + cells expressing intermediate levels of the T cell receptor in the liver and other immune organs. Eur. J. Immunol. 1995. 25: 2272-2278.
39. Moroda, T., Kawachi, Y., Iiai, T., Tsukahara, A., Suzuki, S., Tada, T. Watanabe, H., Hatakeyama, K. and Abo, T. Self-reactive forbidden clones are confined to pathways of intermediate T cell receptor cell differentiation even under immunosuppressive conditions. Immunology 1997. 91: 88-94.
40. Murosaki, S., Yoshikai, Y., Ishida, A., Nakamura, T., Matsuzaki, G., Takimoto, H., Yuuki, H. and Nomoto, K. Failure of T cell receptor V beta negative selection in murine intestinal intraepithelial lymphocytes. Int. Immunol. 1991. 3: 1005-1013.
41. Badiner, G., Goodman, T. G. and Lefrancois, L. Selection of intestinal intraepithelial lymphocyte T cell receptors: evidence for a dynamic tissue-specific process. Int. Immunol. 1993. 5: 223-226.
42. Roark, J. H., Park, S. H., Jayawardena, J., Kavita, U., Shannon, M. and Bendelac, A. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 1998. 160: 3121-3127.
43. Amano, M., Baumgarth, N., Dick, M. D., Brossay, L., Kronenberg, M., Herzenberg, L. A. and Strober, S. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: β2-microglobulin-dependent and independent forms. J. Immunol. 1998. 161: 1710-1717.
44. Kitamura, H., Ohta, A., Sekimoto, M., Sato, M., Iwakabe, K., Nakui, M., Yahata, T., Meng, H., Koda, T., Nishimura, S., Kawano, T., Taniguchi, M. and Nishimura, T. α-galactosylceramide induces early B cell activation through IL-4 production by NKT cells. Cell. Immunol. 2000. 199: 37-42.
45. Moroda, T., Iiai, T., Suzuki, S., Tsukahara, A., Tada, T., Nose, M., Hatakeyama, K., Seki, S., Takeda, K., Watanabe, H. and Abo, T. Autologous killing by a population of intermediate TCR cells and its NK1.1+ and NK1.1- subsets, using Fas ligand/Fas molecules. Immunology 1997. 91: 219-226.
46. Bannai, M., Oya, H., Kawamura, T., Naito, T., Shimizu, T., Kawamura, H., Miyaji, C., Watanabe, H., Hatakeyama, K. and Abo, T. Disparate effect of beige mutation on cytotoxic function between NK and NKT cells. Immunology 2000. 100: 165-169.
47. Smyth, M. J., Thia, K. Y., Street, S. E., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y. and Godfrey, D. I. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 2000. 191: 661-668.
48. Ishihara, S., Nieda, M., Kitayama, J., Osada, T., Yabe, T., Kikuchi, A., Koezuka, Y., Porcelli, S. A., Tadokoro, K., Nagawa, H., and Juji. T. Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro. J. Immunol. 2000. 165: 1659-1664.
49. Shin, T., Nakayama, T., Akutsu, Y., Motohashi, S., Shibata, Y., Harada, M., Kamada, N., Shimizu, C., Shimizu, E., Saito, T., Ochiai, T. and Taniguchi, M. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells. Int. J. Cancer. 2001. 91: 523-528.
50. Smyth, M. J., Taniguchi, M. and Street, S. E. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J. Immunol. 2000. 165: 2665-2670.
51. Nakagawa, R., Nagafune, I., Tazunoki, Y., Ehara, H., Tomura, H., Iijima, R., Motoki, K., Kamishohara, M. and Seki, S. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J. Immunol. 2001. 166: 6578-6584.
52. Smyth, M. J., Crowe, N. Y., and Godfrey, D. I. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int. Immunol. 2001. 13: 459-463.
53. Das, P. K., van den Wijngaard, R. M. J. G. J., Wankowicz-Kalinska, A. and Poole, I. C. L. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends Immunol. 2001. 22: 130-136.
54. Bachmann, M. F. and Kopf, M. On the role of the innate immunity in autoimmune disease. J. Exp. Med. 2001. 193: F47-50.
55. Schwartz, M. and Cohen, I. R. Autoimmunity can benefit self-maintenance. Immunol. Today 2000. 21: 265-268.
56. Shi, F., Ljunggren, H. G. and Sarvetnick, N. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol. 2001. 22: 97-101.
57. Sato, K., Ohtsuka, K., Hasegawa, K., Yamagiwa, S., Watanabe, H., Asakura, H., and Abo, T. Evidence for extrathymic generation of intermediate TCR cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J. Exp. Med. 1995. 182: 759-767.
58. +T cells in various immune organs. NK1.1+T cells are present within a population of intermediate TCR cells. J. Immunol. 1995. 155: 2972-2983.
59. Tsukahara, A., Seki, S., Iiai, T., Moroda, T., Watanabe, H., Suzuki, S., Tada, T., Hiraide, H., Hatakeyama, K. and Abo, T. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology 1997. 26: 301-309.
60. 1 mice with chronic graft-versus-host reaction across MHC class II difference. Autoimmunity 1992. 12: 79-87.
61. Kawamura, H., Kawamura, T., Kokai, Y., Mori, M., Matsuura, A., Oya, H., Honda, S., Suzuki, S., Weerasinghe, A., Watanabe, H. and Abo, T. Expansion of extrathymic T cells as well as granulocytes in the liver and other organs of G-CSF transgenic mice: Why they lost the ability of hybrid resistance. J. Immunol. 1999. 162: 5957-5964.